May 7, 2024

RION Announces First Patient Dosed in Phase 2 Clinical Study of Purified Exosome Product™ for Diabetic Foot Ulcers

February 26, 2024

RION Expands Manufacturing Operations with Cutting-Edge Facility in Rochester, Minnesota

February 23, 2024

RION to Present at the Evercore ISI 2024 Emerging Biotech Conference

January 30, 2024

RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers

January 2, 2024

RION to Present at the 42nd Annual J.P. Morgan Healthcare Conference

November 20, 2023

RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Recieved $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics

January 25, 2023

RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board